Print

an>

Title: Need for research on thalassemia gene therapy.

DR. KIRIT P. SOLANKI (AHMEDABAD): Thalassemia is a genetic blood disorder, which necessitates regular blood transfusions. The estimated number of patients in India is 1,00,000 with approximately 10,000 new cases every year, which constitutes a significant burden.

However, a national prevention and control programme needs to be formulated to adequately address the disease burden. The Central Government should initiate research on Thalassemia gene therapy. It is important to mention the significant strides made by Gujarat in expanding prevention policies with the aim of making the state thalassemia-free. I request the Central Government to replicate these efforts nationwide by drafting and implementing a national policy.

 

 

 

 

 

 

 

 

 

 

Developed and Hosted by National Informatics Centre (NIC)
Content on this website is published, managed & maintained by Software Unit, Computer (HW & SW) Management. Branch, Lok Sabha Secretariat